Medisyn Technologies, Inc. - Product Pipeline Review - H2 2011

Global Markets Direct, November 2011, Pages: 41

Medisyn Technologies, Inc. – Product Pipeline Review – H2 2011

Summary

Global Market Direct’s pharmaceuticals report, “Medisyn Technologies, Inc. - Product Pipeline Review - H2 2011” provides data on the Medisyn Technologies, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Medisyn Technologies, Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from Medisyn Technologies, Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Medisyn Technologies, Inc. - Brief Medisyn Technologies, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Medisyn Technologies, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Medisyn Technologies, Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Medisyn Technologies, Inc.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Medisyn Technologies, Inc.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Medisyn Technologies, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Medisyn Technologies, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Medisyn Technologies, Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Medisyn Technologies, Inc. and identify potential opportunities in those areas.

Keywords

Current R&D Portfolio of Medisyn Technologies, Inc.; Medisyn Technologies, Inc. - Key Therapeutics; Medisyn Technologies, Inc. - Pipeline Overview and Promising Molecules; Medisyn Technologies, Inc. - News; Medisyn Technologies, Inc. - Latest Updates; Medisyn Technologies, Inc. - Pipeline; Medisyn Technologies, Inc. - Discontinued/Dormant Projects

List of Tables
List of Figures
Medisyn Technologies, Inc. Snapshot
Medisyn Technologies, Inc. Overview
Key Information
Key Facts
Medisyn Technologies, Inc. – Research and Development Overview
Key Therapeutic Areas
Medisyn Technologies, Inc. – Pipeline Review
Pipeline Products by Stage of Development
Medisyn Technologies, Inc. – Pipeline Products Glance
Medisyn Technologies, Inc.–Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Medisyn Technologies, Inc. – Drug Profiles
Drug For MRSA
Product Description
Mechanism of Action
R&D Progress
Drug For Premature Ejaculation
Product Description
Mechanism of Action
R&D Progress
Drug For Tuberculosis
Product Description
Mechanism of Action
R&D Progress
MC4R Agonist
Product Description
Mechanism of Action
R&D Progress
MT062
Product Description
Mechanism of Action
R&D Progress
MT103
Product Description
Mechanism of Action
R&D Progress
MT477
Product Description
Mechanism of Action
R&D Progress
Non-Steroidal Anti-Inflammatory Drug
Product Description
Mechanism of Action
R&D Progress
PDE5 Inhibition
Product Description
Mechanism of Action
R&D Progress
Protease Inhibitor
Product Description
Mechanism of Action
R&D Progress
Medisyn Technologies, Inc. – Pipeline Analysis
Medisyn Technologies, Inc. – Pipeline Products by Therapeutic Class
Medisyn Technologies, Inc. - Pipeline Products By Target
Medisyn Technologies, Inc. – Pipeline Products by Route of Administration
Medisyn Technologies, Inc. – Pipeline Products by Molecule Type
Medisyn Technologies, Inc. – Locations And Subsidiaries
Head Office
Recent Developments
Sep 13, 2007: Mount Sinai School Of Medicine And Medisyn Technologies Announce Agreement To Discover Novel Therapeutics For Treating Alzheimer's Disease
Mar 03, 2010: Mount Sinai School Of Medicine And Medisyn Technologies Discover Novel Compounds For Alzheimer's Treatment
Mar 03, 2010: Mount Sinai School Of Medicine And Medisyn Technologies Discover Novel Compounds For Alzheimer's Treatment
Financial Deals Landscape
Medisyn Technologies, Inc., Deals Summary
Medisyn Technologies, Inc., Pharmaceuticals & Healthcare, Deal Details
Venture Financing
Medisyn Technologies Secures $1.5 Million In Venture Financing Round
Partnerships
Kraft Foods Enters Into Collaboration Agreement With Medisyn Technologies
Mount Sinai School Of Medicine Enters Into Co-development Agreement With Medisyn Technologies
MD Biosciences Enters Into Co-Development Agreement With Medisyn Technologies
Medisyn Technologies Enters Into Co-Development Agreement With Humanetics
Invitrogen Enters Into Research Agreement With Medisyn Technologies
Licensing Agreements
Eidogen-Sertanty Enters Into Licensing Agreement With Medisyn Technologies
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Medisyn Technologies, Inc. – Pipeline by Therapy Area and Indication, H2 2011
Medisyn Technologies, Inc. – Pipeline by Stage of Development, H2 2011
Medisyn Technologies, Inc. - Pipeline By Therapeutic Class, H2 2011
Medisyn Technologies, Inc. - Pipeline By Target, H2 2011
Medisyn Technologies, Inc. – Pipeline By Route of Administration, H2 2011
Medisyn Technologies, Inc. – Pipeline By Molecule Type, H2 2011
Medisyn Technologies, Inc., Deals Summary
Medisyn Technologies Secures $1.5 Million In Venture Financing Round
Kraft Foods Enters Into Collaboration Agreement With Medisyn Technologies
Mount Sinai School Of Medicine Enters Into Co-development Agreement With Medisyn Technologies
MD Biosciences Enters Into Co-Development Agreement With Medisyn Technologies
Medisyn Technologies Enters Into Co-Development Agreement With Humanetics
Invitrogen Enters Into Research Agreement With Medisyn Technologies
Eidogen-Sertanty Enters Into Licensing Agreement With Medisyn Technologies

List of Figures
Medisyn Technologies, Inc. – Pipeline by Therapy Area and Indication, H2 2011
Medisyn Technologies, Inc. – Pipeline by Stage of Development, H2 2011
Medisyn Technologies, Inc. – Pipeline By Therapeutic Class, H2 2011
Medisyn Technologies, Inc. - Pipeline By Target, H2 2011
Medisyn Technologies, Inc. – Pipeline By Molecule Type, H2 2011

Customers who bought this item also bought

• Akamai Technologies, Inc.
• Top Five Global Software Companies: Performance, Strategies and Competitive Analysis
• Scientific Games Corporation - Company Analysis
• Hewlett-Packard Company - Strategies, Financial Outlook and Competitive Benchmark Analysis
• Apple, Inc. - Strategies, Financial Outlook and Competitive Benchmark Analysis
• Ixia - Company Analysis
• Lionbridge Technologies Inc,(LIOX) Profile and Financials, plus E-Commerce & Internet Industry Trends Analysis, Operating Ratio and Financial Averages
• Onemove Technologies, Inc.,(OM) Profile and Financials, plus E-Commerce & Internet Industry Trends Analysis, Operating Ratio and Financial Averages
• Akamai Technologies Inc,(AKAM) Profile and Financials, plus E-Commerce & Internet Industry Trends Analysis, Operating Ratio and Financial Averages
• Westell Technologies Inc,(WSTL) Profile and Financials, plus E-Commerce & Internet Industry Trends Analysis, Operating Ratio and Financial Averages